Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Not yet recruiting × Small Cell Lung Carcinoma × sintilimab × Clear all

Phase

Status

Unknown 4 Not yet recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Stomach Neoplasms 10 Carcinoma, Hepatocellular 10 Carcinoma, Non-Small-Cell Lung 5 Rectal Neoplasms 3 Nasopharyngeal Carcinoma 3 Esophageal Squamous Cell Carcinoma 3 Recurrence 2 Colorectal Neoplasms 2 Colonic Neoplasms 2 Breast Neoplasms 2 Uterine Cervical Neoplasms 1 Turcot syndrome 1 Thyroid Neoplasms 1 Squamous Non-Small Cell Lung Cancer SqNSCLC 1 Spinocerebellar Degenerations 1 Small Cell Lung Carcinoma 1 Resectable Non-small Cell Lung Cancer 1 Rare Tumour 1 Pancreatic Neoplasms 1 Pancreatic Cancer Resectable 1 Pancreatic Cancer Metastatic 1 Neoplasms 1 Neoplasm Metastasis 1 Lymphoma, Large B-Cell, Diffuse 1 Lung Neoplasms 1 Locally Advanced Non-Small Cell Lung Cancer 1 Liver Neoplasms 1 Hodgkin Disease 1 HER2-positive Advanced Gastric Cancer or Gastroesophageal Junction Adenocarcinoma 1 Esophageal Neoplasms 1

Interventions

Etoposide 14 Carboplatin 12 Cisplatin 7 anlotinib 6 Radiotherapy 5 PM 01183 5 Drug Therapy 5 toripalimab 4 tislelizumab 4 durvalumab 4 Topotecan 4 Platinum 4 irinotecan sucrosofate 3 atezolizumab 3 famitinib 2 apatinib 2 Pemetrexed 2 Paclitaxel 2 surufatinib 1 sintilimab 1 sacituzumab govitecan 1 osimertinib 1 nintedanib 1 fludarabine 1 amrubicin 1 Tomography, X-Ray Computed 1 Radiation Dose Hypofractionation 1 Rabeprazole 1 Proton Pump Inhibitors 1 Platinum Compounds 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT07061535 2025-07-11

STAR-SCLC

Second Affiliated Hospital, School of Medicine, Zhejiang University

Phase 2 Not yet recruiting

Small Cell Lung Carcinoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡